The Effect of Subcutaneous Brodalumab upon Clinical Disease Activity in Hidradenitis Suppurativa: An Open Label Cohort Study

Published: 1 May 2020| Version 1 | DOI: 10.17632/98pmyyz67m.1
Contributor:
John Frew

Description

Supplementary Material

Files